Skip to main content
Erschienen in:

15.01.2024 | Cardiac

Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis

verfasst von: Zhong-Fei Lu, Wei-Hua Yin, U. Joseph Schoepf, Sameer Abrol, Jing-Wen Ma, Li Zhao, Xiao-Ming Su, Yun-Qiang An, Zhi-Cheng Xiao, Bin Lu

Erschienen in: European Radiology | Ausgabe 8/2024

Einloggen, um Zugang zu erhalten

Abstract

Objectives

As a novel imaging marker, pericoronary fat attenuation index (FAI) reflects the local coronary inflammation which is one of the major mechanisms for in-stent restenosis (ISR). We aimed to validate the ability of pericoronary FAI to predict ISR in patients undergoing percutaneous coronary intervention (PCI).

Materials and methods

Patients who underwent coronary CT angiography (CCTA) before PCI within 1 week between January 2017 and December 2019 at our hospital and had follow-up invasive coronary angiography (ICA) or CCTA were enrolled. Pericoronary FAI was measured at the site where stents would be placed. ISR was defined as ≥ 50% diameter stenosis at follow-up ICA or CCTA in the in-stent area. Multivariable analysis using mixed effects logistic regression models was performed to test the association between pericoronary FAI and ISR at lesion level.

Results

A total of 126 patients with 180 target lesions were included in the study. During 22.5 months of mean interval time from index PCI to follow-up ICA or CCTA, ISR occurred in 40 (22.2%, 40/180) stents. Pericoronary FAI was associated with a higher risk of ISR (adjusted OR = 1.12, p = 0.028). The optimum cutoff was − 69.6 HU. Integrating the dichotomous pericoronary FAI into current state of the art prediction model for ISR improved the prediction ability of the model significantly (△area under the curve =  + 0.064; p = 0.001).

Conclusion

Pericoronary FAI around lesions with subsequent stent placement is independently associated with ISR and could improve the ability of current prediction model for ISR.

Clinical relevance statement

Pericoronary fat attenuation index can be used to identify the lesions with high risk for in-stent restenosis. These lesions may benefit from extra anti-inflammation treatment to avoid in-stent restenosis.

Key Points

• Pericoronary fat attenuation index reflects the local coronary inflammation.
• Pericoronary fat attenuation index around lesions with subsequent stents placement can predict in-stent restenosis.
• Pericoronary fat attenuation index can be used as a marker for future in-stent restenosis.

Graphical Abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Windecker S, Serruys PW, Wandel S et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372:1163–1173CrossRefPubMed Windecker S, Serruys PW, Wandel S et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372:1163–1173CrossRefPubMed
2.
Zurück zum Zitat Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R (2010) In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 56:1897–1907CrossRefPubMed Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R (2010) In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 56:1897–1907CrossRefPubMed
3.
Zurück zum Zitat Moussa ID, Mohananey D, Saucedo J et al (2020) Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol 76:1521–1531CrossRefPubMed Moussa ID, Mohananey D, Saucedo J et al (2020) Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol 76:1521–1531CrossRefPubMed
4.
Zurück zum Zitat Niccoli G, Montone RA, Sabato V, Crea F (2018) Role of allergic inflammatory cells in coronary artery disease. Circulation 138:1736–1748CrossRefPubMed Niccoli G, Montone RA, Sabato V, Crea F (2018) Role of allergic inflammatory cells in coronary artery disease. Circulation 138:1736–1748CrossRefPubMed
5.
Zurück zum Zitat Borovac JA, D’Amario D, Vergallo R et al (2019) Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother 5:105–116CrossRefPubMed Borovac JA, D’Amario D, Vergallo R et al (2019) Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother 5:105–116CrossRefPubMed
6.
Zurück zum Zitat Shlofmitz E, Iantorno M, Waksman R (2019) Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv 12:e007023CrossRefPubMed Shlofmitz E, Iantorno M, Waksman R (2019) Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv 12:e007023CrossRefPubMed
7.
Zurück zum Zitat Yi M, Wu L, Ke X (2022) Prognostic value of high-sensitivity C-reactive protein in in-stent restenosis: a meta-analysis of clinical trials. J Cardiovasc Dev Dis 9:247 Yi M, Wu L, Ke X (2022) Prognostic value of high-sensitivity C-reactive protein in in-stent restenosis: a meta-analysis of clinical trials. J Cardiovasc Dev Dis 9:247
8.
Zurück zum Zitat Yousuf O, Mohanty BD, Martin SS et al (2013) High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62:397–408CrossRefPubMed Yousuf O, Mohanty BD, Martin SS et al (2013) High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62:397–408CrossRefPubMed
9.
Zurück zum Zitat Antonopoulos AS, Margaritis M, Coutinho P et al (2015) Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 64:2207–2219CrossRefPubMed Antonopoulos AS, Margaritis M, Coutinho P et al (2015) Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 64:2207–2219CrossRefPubMed
10.
Zurück zum Zitat Margaritis M, Antonopoulos AS, Digby J et al (2013) Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 127:2209–2221CrossRefPubMed Margaritis M, Antonopoulos AS, Digby J et al (2013) Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 127:2209–2221CrossRefPubMed
11.
Zurück zum Zitat Antonopoulos AS, Sanna F, Sabharwal N et al (2017) Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med 9:eaal2658 Antonopoulos AS, Sanna F, Sabharwal N et al (2017) Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med 9:eaal2658
12.
Zurück zum Zitat Oikonomou EK, Marwan M, Desai MY et al (2018) Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet 392:929–939CrossRefPubMedPubMedCentral Oikonomou EK, Marwan M, Desai MY et al (2018) Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet 392:929–939CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Goeller M, Tamarappoo BK, Kwan AC et al (2019) Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging 20:636–643CrossRefPubMedPubMedCentral Goeller M, Tamarappoo BK, Kwan AC et al (2019) Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging 20:636–643CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Goeller M, Achenbach S, Cadet S et al (2018) Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease. JAMA Cardiol 3:858–863CrossRefPubMedPubMedCentral Goeller M, Achenbach S, Cadet S et al (2018) Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease. JAMA Cardiol 3:858–863CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Oikonomou EK, Williams MC, Kotanidis CP et al (2019) A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J 40:3529–3543CrossRefPubMedPubMedCentral Oikonomou EK, Williams MC, Kotanidis CP et al (2019) A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J 40:3529–3543CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Abbara S, Blanke P, Maroules CD et al (2016) SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 10:435–449CrossRefPubMed Abbara S, Blanke P, Maroules CD et al (2016) SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 10:435–449CrossRefPubMed
17.
Zurück zum Zitat Pan J, Lu Z, Zhang J, Li M, Wei M (2013) Angiographic patterns of in-stent restenosis classified by computed tomography in patients with drug-eluting stents: correlation with invasive coronary angiography. Eur Radiol 23:101–107CrossRefPubMed Pan J, Lu Z, Zhang J, Li M, Wei M (2013) Angiographic patterns of in-stent restenosis classified by computed tomography in patients with drug-eluting stents: correlation with invasive coronary angiography. Eur Radiol 23:101–107CrossRefPubMed
18.
Zurück zum Zitat Li Y, Yu M, Li W, Lu Z, Wei M, Zhang J (2018) Third generation dual-source CT enables accurate diagnosis of coronary restenosis in all size stents with low radiation dose and preserved image quality. Eur Radiol 28:2647–2654CrossRefPubMed Li Y, Yu M, Li W, Lu Z, Wei M, Zhang J (2018) Third generation dual-source CT enables accurate diagnosis of coronary restenosis in all size stents with low radiation dose and preserved image quality. Eur Radiol 28:2647–2654CrossRefPubMed
19.
Zurück zum Zitat Min JK, Shaw LJ, Devereux RB et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50:1161–1170CrossRefPubMed Min JK, Shaw LJ, Devereux RB et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50:1161–1170CrossRefPubMed
20.
Zurück zum Zitat Pencina MJ, D’Agostino RB, Pencina KM, Janssens AC, Greenland P (2012) Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 176:473–481CrossRefPubMedPubMedCentral Pencina MJ, D’Agostino RB, Pencina KM, Janssens AC, Greenland P (2012) Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 176:473–481CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Toutouzas K, Colombo A, Stefanadis C (2004) Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25:1679–1687CrossRefPubMed Toutouzas K, Colombo A, Stefanadis C (2004) Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25:1679–1687CrossRefPubMed
22.
Zurück zum Zitat Madjid M, Willerson JT, Casscells SW (2006) Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol 47:C80-85CrossRefPubMed Madjid M, Willerson JT, Casscells SW (2006) Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol 47:C80-85CrossRefPubMed
23.
Zurück zum Zitat Stefanadis C, Toutouzas K, Tsiamis E et al (2001) Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 37:1277–1283CrossRefPubMed Stefanadis C, Toutouzas K, Tsiamis E et al (2001) Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 37:1277–1283CrossRefPubMed
24.
Zurück zum Zitat Gugliandolo E, Fusco R, Biundo F et al (2017) Palmitoylethanolamide and polydatin combination reduces inflammation and oxidative stress in vascular injury. Pharmacol Res 123:83–92CrossRefPubMed Gugliandolo E, Fusco R, Biundo F et al (2017) Palmitoylethanolamide and polydatin combination reduces inflammation and oxidative stress in vascular injury. Pharmacol Res 123:83–92CrossRefPubMed
25.
Zurück zum Zitat Wang R, Lu J, Yin J et al (2023) A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation. Bioact Mater 19:666–677PubMed Wang R, Lu J, Yin J et al (2023) A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation. Bioact Mater 19:666–677PubMed
26.
Zurück zum Zitat Park JH, Kim SW, Cha MJ et al (2018) TAK-733 inhibits inflammatory neointimal formation by suppressing proliferation, migration, and inflammation in vitro and in vivo. Exp Mol Med 50:1–12PubMedPubMedCentral Park JH, Kim SW, Cha MJ et al (2018) TAK-733 inhibits inflammatory neointimal formation by suppressing proliferation, migration, and inflammation in vitro and in vivo. Exp Mol Med 50:1–12PubMedPubMedCentral
27.
Zurück zum Zitat Qiu H, Tu Q, Gao P et al (2021) Phenolic-amine chemistry mediated synergistic modification with polyphenols and thrombin inhibitor for combating the thrombosis and inflammation of cardiovascular stents. Biomaterials 269:120626CrossRefPubMed Qiu H, Tu Q, Gao P et al (2021) Phenolic-amine chemistry mediated synergistic modification with polyphenols and thrombin inhibitor for combating the thrombosis and inflammation of cardiovascular stents. Biomaterials 269:120626CrossRefPubMed
28.
Zurück zum Zitat Ohyama K, Matsumoto Y, Takanami K et al (2018) Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol 71:414–425CrossRefPubMed Ohyama K, Matsumoto Y, Takanami K et al (2018) Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol 71:414–425CrossRefPubMed
29.
Zurück zum Zitat Antonopoulos AS, Antoniades C (2018) Perivascular fat attenuation index by computed tomography as a metric of coronary inflammation. J Am Coll Cardiol 71:2708–2709CrossRefPubMed Antonopoulos AS, Antoniades C (2018) Perivascular fat attenuation index by computed tomography as a metric of coronary inflammation. J Am Coll Cardiol 71:2708–2709CrossRefPubMed
30.
Zurück zum Zitat Ridker PM (2016) A Test in Context: High-Sensitivity C-Reactive Protein. J Am Coll Cardiol 67:712–723CrossRefPubMed Ridker PM (2016) A Test in Context: High-Sensitivity C-Reactive Protein. J Am Coll Cardiol 67:712–723CrossRefPubMed
31.
Zurück zum Zitat Kastrati A, Dibra A, Mehilli J et al (2006) Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113:2293–2300CrossRefPubMed Kastrati A, Dibra A, Mehilli J et al (2006) Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113:2293–2300CrossRefPubMed
32.
Zurück zum Zitat Giustino G, Colombo A, Camaj A et al (2022) Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol 80:348–372CrossRefPubMed Giustino G, Colombo A, Camaj A et al (2022) Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol 80:348–372CrossRefPubMed
Metadaten
Titel
Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis
verfasst von
Zhong-Fei Lu
Wei-Hua Yin
U. Joseph Schoepf
Sameer Abrol
Jing-Wen Ma
Li Zhao
Xiao-Ming Su
Yun-Qiang An
Zhi-Cheng Xiao
Bin Lu
Publikationsdatum
15.01.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2024
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10527-0

Neu im Fachgebiet Radiologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

PMBCL mit CMR: Radiatio kann ohne Risiko weggelassen werden

Patienten mit primär mediastinalem B-Zell-Lymphom (PMBCL), die nach der Induktionstherapie eine komplette metabolische Remission (CMR) erreichen und keine konsolidierende Bestrahlung erhalten, müssen offenbar keine Überlebensnachteile fürchten.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.